 |
Corporate News
30-Nov-22
|
|
|
|
|
|
|
|
|
|
|
|
J B Chemical receives USFDA approval for Venlafaxine Extended Release Tablets
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals has received ANDA approval from the USFDA for Venlafaxine Extended Release Tablets 37.5mg, 75mg, 150mg and 225mg. This product is based on OROS (Osmotic Controlled Release Oral Delivery System) technology, an advanced and precision-controlled release mechanism. The generic product approval is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 75 mg, 150 mg, and
225 mg, of Osmotica Pharmaceutical U.S. LLC.
As per IQVIA Health MAT Oct 2022 data, Venlafaxine Extended-Release tablets recorded annualized sales of approximately $ 48 million in the US.
|
|
|
|
Previous News |
J B Chemicals & Pharmaceuticals completes acquisition of portfolio of brands from Dr Reddy's
(
Corporate News
-
21-Jul-22
19:03
)
|
|
|
J B Chemicals & Pharmaceuticals standalone net profit rises 14.42% in the September 2017 quarter
(
Results
-
Announcements
10-Nov-17
16:11
)
|
|
|
Board of J B Chemicals & Pharmaceuticals recommends final dividend
(
Corporate News
-
27-May-23
17:59
)
|
|
|
J B Chemicals CFO Lakshay Kataria resigns
(
Hot Pursuit
-
08-Sep-23
08:34
)
|
|
|
J B Chemicals & Pharmaceuticals standalone net profit rises 24.54% in the September 2021 quarter
(
Results
-
Announcements
12-Nov-21
16:54
)
|
|
|
J B Chemicals & Pharmaceuticals to acquire Razel franchise for India and Nepal region
(
Corporate News
-
14-Dec-22
19:21
)
|
|
|
Board of J B Chemicals & Pharmaceuticals appoints director and CEO
(
Corporate News
-
05-Oct-20
13:27
)
|
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 132.51% in the December 2020 quarter
(
Results
-
Announcements
11-Feb-21
08:35
)
|
|
|
Board of J B Chemicals & Pharmaceuticals recommends Final Dividend
(
Corporate News
-
26-Jun-20
10:41
)
|
|
|
Board of J B Chemicals & Pharmaceuticals to consider buyback of shares
(
Corporate News
-
23-Aug-18
14:43
)
|
|
|
J B Chemicals & Pharmaceuticals standalone net profit rises 53.62% in the September 2015 quarter
(
Results
-
Announcements
05-Nov-15
09:40
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|